Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Controlled trial of aspirin in cerebral ischemia.
1977437 citationsWilliam S. Fields, Noreen A. Lemak et al.Strokeprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Noreen A. Lemak
Since
Specialization
Citations
This map shows the geographic impact of Noreen A. Lemak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noreen A. Lemak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noreen A. Lemak more than expected).
This network shows the impact of papers produced by Noreen A. Lemak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noreen A. Lemak. The network helps show where Noreen A. Lemak may publish in the future.
Co-authorship network of co-authors of Noreen A. Lemak
This figure shows the co-authorship network connecting the top 25 collaborators of Noreen A. Lemak.
A scholar is included among the top collaborators of Noreen A. Lemak based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Noreen A. Lemak. Noreen A. Lemak is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Khalil, Samia N., Kim Lawson, Craig L. Hanis, Noreen A. Lemak, & Robert R. German. (1999). Alfentanil decreases myoclonus caused by etomidate.. PubMed. 15(2). 185–92.16 indexed citations
Fields, William S. & Noreen A. Lemak. (1989). A History of Stroke: Its Recognition and Treatment. Medical Entomology and Zoology.20 indexed citations
15.
Fields, William S. & Noreen A. Lemak. (1987). Trigeminal neuralgia: historical background, etiology, and treatment.. PubMed. 3(2). 47–56.5 indexed citations
16.
Fields, William S., Noreen A. Lemak, & Yoram Ben‐Menachem. (1986). Thoracic Outlet Syndrome: Review and Reference to Stroke in a Major League Pitcher. American Journal of Neuroradiology. 7(1). 73–78.7 indexed citations
Fields, William S., Noreen A. Lemak, Ralph F. Frankowski, Robert J. Hardy, & Robert Bigelow. (1980). Controlled trial of aspirin in cerebral ischemia.. PubMed. 62(6 Pt 2). V90–6.23 indexed citations
Fields, William S. & Noreen A. Lemak. (1972). Joint Study of extracranial arterial occlusion. VII. Subclavian steal--a review of 168 cases.. PubMed. 222(9). 1139–43.45 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.